Tabrecta (Capmatinib)

Prescription medicineOnly Available By Prescription

Top brand choice

Strength Pack Size Qty
Pack Size
Pack Size
Pack Size

You'll have option to make 4 interest-free payments by credit card once your order is confirmed using

What if I find a lower price with another pharmacy?

We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!

Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.

To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.

Terms & Conditions of Program

  • Guaranteed lowest price is only valid at the time of sale.
  • We will only match the current advertised price.
  • Products must be identical and in stock at the time of placing an order with a licensed mail order pharmacy. They must be an online Canadian pharmacy with an address in Canada.
  • Products must be authentic in brand and size (same manufacturer, same country of manufacture, same pack size, same strength and same quantity).
  • Products must be new. We cannot match the price of any used, short expiry or expired product.
  • Price match can only be issued over the phone with our customer service team. Please note at this time we cannot offer price matching for the products Ozempic or Saxenda.
What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.


Tabrecta (Capmatinib) is a prescription drug classified as a kinase inhibitor. It targets non-small cell lung cancer (NSCLC) in adults where the cancer has metastasized and cannot be removed by surgery. By blocking proteins on the MET gene in cancer cells, this medication may help slow tumor growth. Doctors and healthcare providers typically test for this gene before prescribing Tabrecta.


Take Tabrecta orally as directed by a healthcare provider. The standard dosage is 400 mg taken twice daily, amounting to a total of 800 mg per day. Swallow the tablets whole without crushing or chewing them. Tabrecta tablets may be taken with or without food. If a dose is missed within 12 hours of the next dose, skip it and proceed with the regular dosing schedule.


Tabrecta contains the active ingredient Capmatinib. Inactive ingredients may also be included that improve the drug’s absorption into the body. These ingredients may include magnesium stearate, colloidal silicon dioxide, and mannitol, among others.


No contraindications have been reported, according to the official drug label.


  • Before starting Tabrecta, tell your doctor about:
    • Any other medications you are taking, including over-the-counter drugs, vitamins, or herbal supplements.
    • Existing health conditions, particularly liver problems.
    • Pregnancy or intent to become pregnant. Tabrecta may be harmful to a developing fetus.
    • If you are breastfeeding. The medication could pass into breast milk and potentially harm a nursing baby.
  • Watch for any new or worsening symptoms in your lungs, such as difficulty breathing or coughing, as these could indicate interstitial lung disease (ILD) or pneumonitis. If these symptoms arise, Tabrecta should be stopped permanently.
  • Tabrecta can affect liver health (hepatotoxicity). You may need regular liver function tests while on this medication. Depending on the liver test results, your doctor might adjust your dose or stop Tabrecta altogether.
  • There's also a risk of pancreatic toxicity. Your healthcare provider will monitor your amylase and lipase levels to check your pancreatic function. Depending on the test results, your treatment plan may be adjusted.
  • If you experience any hypersensitivity reactions, such as rash, itching, or difficulty breathing, Tabrecta may need to be paused or stopped based on how severe the reaction is.
  • Tabrecta can increase your sensitivity to sunlight (photosensitivity). It's recommended to limit your exposure to direct sunlight and UV rays to prevent skin reactions.
  • Tabrecta may harm an unborn baby. If you are pregnant or planning to become pregnant, discuss this risk with your doctor. Use effective contraception during treatment to prevent pregnancy.

Side Effects

Tabrecta may cause a range of side effects. The most common Tabrecta side effects include headache, muscle or bone pain, and swelling of the face, arms, hands, lower legs, or feet. Patients might also experience cough, decreased appetite, nausea, and vomiting.

The medication can also lead to more serious side effects that may require immediate medical attention. This includes lung or breathing problems such as inflammation of the lungs, which can be fatal. Symptoms of lung issues include a new or worsening cough, fever, and difficulty breathing. In addition, Tabrecta may cause liver problems, with symptoms like yellow skin or eyes, dark urine, and fatigue. Any new or worsening health concerns should always be discussed with a healthcare provider.


  1. Tabrecta (Capmatinib) Product Monograph. East Hanover, NJ: Novartis Pharmaceuticals; 2023.
  2. Tabrecta (Capmatinib) Drug Label Information. East Hanover, NJ: Novartis Pharmaceuticals; 2023.

IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

product-reviews Product Reviews